14 results
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
, emission, discharge, leaking, emptying, pumping, pouring, injection, deposit, dumping, disposal, dispersal, leaching, escaping, migration, or other
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
, emission, discharge, leaking, emptying, pumping, pouring, injection, deposit, dumping, disposal, dispersal, leaching, escaping, migration, or other
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
and manufacturing with Lantheus’ commercial leadership in prostate-specific membrane antigen - positron emission tomography ("PSMA-PET") and radiopharmaceuticals … approved the first drug for positron emission tomography ("PET") imaging of PSMA-positive lesions in individuals with prostate cancer, 68Ga-PSMA-11. In May
8-K
EX-99.2
PNT
POINT Biopharma Global Inc.
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
emission tomography–computed tomography; PR, partial response; PSA, prostate-specific antigen; PSMA, prostate-specific membrane antigen; pts, participants
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
over-expresses PSMA. In December 2020 the FDA approved the first drug for positron emission tomography ("PET") imaging of PSMA positive lesions in men
POS AM
m75p hugup9
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
EX-99.1
frb dtb6t2pgubk0ujb
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
yrfi72ztyrorcpn
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
39ef6 zm2
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
g8doho8fig594f7
5 Aug 21
Prospectus supplement
4:26pm
S-4
EX-10.17
9yf2c uc6
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
nyw xw8wfut89kvi8ug
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
- Prev
- 1
- Next